Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida and currently employs 477 full-time employees. The company went IPO on 2021-04-23. The firm is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. The company has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The company also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The firm sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Follow-Up Questions
Who is the CEO of Treace Medical Concepts Inc?
Mr. John Treace is the Chairman of the Board of Treace Medical Concepts Inc, joining the firm since 2014.
What is the price performance of TMCI stock?
The current price of TMCI is $6.43, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Treace Medical Concepts Inc?
Treace Medical Concepts Inc belongs to Health Care industry and the sector is Health Care
What is Treace Medical Concepts Inc market cap?
Treace Medical Concepts Inc's current market cap is $406.4M
Is Treace Medical Concepts Inc a buy, sell, or hold?
According to wall street analysts, 8 analysts have made analyst ratings for Treace Medical Concepts Inc, including 3 strong buy, 4 buy, 5 hold, 0 sell, and 3 strong sell
